Spyre Therapeutics, Inc. (SYRE)
USD 13.02
(6.55%)
USD 13.02
(6.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 886 Thousand | 2.32 Million | 18.73 Million | - | - | 3.88 Million |
| Cost of Revenue | 964 Thousand | 1.96 Million | 2 Million | 1.62 Million | 901 Thousand | - |
| Gross Profit | -78 Thousand | 365 Thousand | 16.73 Million | -1.62 Million | -901 Thousand | 3.88 Million |
| Operating Expenses | 243.18 Million | 87.11 Million | 84.38 Million | 81.48 Million | 79.43 Million | 49.05 Million |
| Selling, General and Administrative Expenses | 39.94 Million | 28.53 Million | 27.31 Million | 21.84 Million | 14.83 Million | 12.33 Million |
| Research and Development Expenses | 89.5 Million | 58.57 Million | 57.06 Million | 59.63 Million | 64.59 Million | 36.71 Million |
| Other Expenses | 113.73 Million | -7000.00 | -122 Thousand | -5000.00 | - | - |
| Cost and Expenses | 243.18 Million | 87.11 Million | 84.38 Million | 81.48 Million | 80.33 Million | 49.35 Million |
| Operating Income | -242.3 Million | -84.78 Million | -65.64 Million | -81.48 Million | -80.33 Million | -45.46 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -26 Thousand | -136 Thousand | 141 Thousand | -593 Thousand | - | - |
| Earnings before Tax | -338.81 Million | -83.95 Million | -65.66 Million | -80.89 Million | -78.25 Million | -44.34 Million |
| Net Income | -338.79 Million | -83.81 Million | -65.8 Million | -80.89 Million | -78.25 Million | -44.34 Million |
| Earnings Per Share Basic | -49.12 | -24.86 | -25.02 | -37.89 | -61.23 | -53.25 |
| Earnings Per Share Diluted | -49.12 | -24.86 | -25.02 | -37.89 | -61.23 | -53.25 |
| Weighted Average Shares Outstanding | 6.89 Million | 3.37 Million | 2.62 Million | 2.13 Million | 1.27 Million | 832.9 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 6.89 Million | 3.37 Million | 2.62 Million | 2.13 Million | 1.27 Million | 832.9 Thousand |
| Gross Margin | -0.09 | 0.16 | 0.89 | - | - | 1.00 |
| EBIT Margin | -273.48 | -35.73 | -3.42 | - | - | -11.62 |
| Profit Margin | -382.38 | -35.99 | -3.51 | - | - | -11.41 |
| EBITDA | -242.3 Million | -83.21 Million | -63.65 Million | -79.26 Million | -77.35 Million | -45.17 Million |
| Earnings Before Tax Margin | -273.48 | -36.40 | -3.50 | - | - | -11.69 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 886 Thousand | 1.04 Million | - | 688 Thousand |
| Cost of Revenue | - | - | 964 Thousand | 964 Thousand | - | 416 Thousand |
| Gross Profit | - | - | -78 Thousand | 78 Thousand | - | 272 Thousand |
| Operating Expenses | 44.14 Million | 47.77 Million | 129.45 Million | 47.75 Million | 33.24 Million | 29.44 Million |
| Selling, General and Administrative Expenses | 11.51 Million | 12.84 Million | - | 14.07 Million | 8.58 Million | 12.06 Million |
| Research and Development Expenses | 32.63 Million | 34.92 Million | - | 33.68 Million | 24.66 Million | 17.38 Million |
| Other Expenses | -610 Thousand | -483 Thousand | -19.13 Million | -21.39 Million | 2.34 Million | -8000.00 |
| Cost and Expenses | 44.14 Million | 47.77 Million | 129.45 Million | 47.75 Million | 33.24 Million | 29.44 Million |
| Operating Income | -44.14 Million | -47.77 Million | -242.3 Million | -45.91 Million | -18.33 Million | -159.24 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -32 Thousand | -26 Thousand | -5.74 Million | 3000.00 | 7000.00 |
| Earnings before Tax | -38.83 Million | -43.82 Million | -338.81 Million | -63.18 Million | -40.1 Million | -217.07 Million |
| Net Income | -38.83 Million | -43.85 Million | -338.79 Million | -63.18 Million | -40.1 Million | -217.08 Million |
| Earnings Per Share Basic | -0.86 | -1.20 | - | -4.05 | -9.34 | -56.79 |
| Earnings Per Share Diluted | -0.86 | -1.20 | - | -4.05 | -9.34 | -56.79 |
| Weighted Average Shares Outstanding | 45.31 Million | 36.51 Million | 6.89 Million | 15.6 Million | 4.29 Million | 3.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.31 Million | 36.51 Million | 6.89 Million | 15.6 Million | 4.29 Million | 3.82 Million |
| Gross Margin | - | - | -0.09 | 0.07 | - | 0.40 |
| EBIT Margin | - | - | - | -47.60 | - | 233.25 |
| Profit Margin | - | - | -382.38 | -60.63 | - | -315.52 |
| EBITDA | -44.14 Million | -47.77 Million | - | -49.59 Million | -22.79 Million | 160.47 Million |
| Earnings Before Tax Margin | - | - | -273.48 | -44.06 | - | -231.46 |
2050
PRD
ALBPK
AAIL
2015
VARN